IN
Intelligent Bio Solutions Inc.
INBS · NASDAQ
$1.91 -1.55% (-$0.03)
1M -26.42%
Market Cap $1.29M
P/E Ratio -
Div. Yield -
ROE 170.37%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.31x
P/B 0.23x
P/E N/A
Growth
99 /100
Growing Rev. growth 49.68%
Book val. growth 13.20%
EPS growth N/A
Profitability
19 /100
Weak Gross margin 48.63%
FCF margin 289.53%
Net margin 294.91%
Quality
4 /100
Poor ROIC 176.09%
Asset turnover 0.35x
ROE 170.37%
Debt
61 /100
Moderate Debt/Equity 0.33x
Int. coverage -1,160.39x
Current ratio 1.44x
Stability
31 /100
Unstable Beta 4.25x
Profitable years 0
Rev. volatility 77.39%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na INBS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Harry Simeonidis
Employees
58
Headquarters
New York City
Nadcházející události
11 LIS
Earnings
Upcoming earnings report